Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Last updated: September 2018
Remove filter for
Last updated: 2018
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 2 of 2 items.
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Nephritis
AlertHealth professional risk communication | 2018-09-18
Tromboject 1% and 3% (sodium tetradecyl sulfate) with Visible Particles - Update on the Use of Medical Grade Filters
AlertHealth professional risk communication | 2018-09-12